@techreport{i22,
author = {{IQVIA Institute for Human Data Science}},
month = {April},
title = {The use of medicines in the U.S. 2022: Usage and spending trends and outlook to 2026},
year = {2022},
url = {https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/the-use-of-medicines-in-the-us-2022/iqvia-institute-the-use-of-medicines-in-the-us-2022.pdf},
}

@article{bdk18,
author = {Beall, R. and Darrow, J. and Kesselheim, A.},
journal = {Value in Health},
month = {June},
number = {12},
pages = {P1382-1389},
title = {A method for approximating future entry of generic drugs},
volume = {21},
year = {2018},
doi = {https://doi.org/10.1016/j.jval.2018.04.1827},
}

@article{btr16,
author = {Branco, P. and Torgo, L. and Ribeiro, R. P.},
journal = {ACM Computing Surveys (CSUR)},
number = {2},
pages = {1-50},
title = {A survey of predictive modeling on imbalanced domains},
volume = {49},
year = {2016},
}

@article{bbc20,
author = {Buckley, L. A. and Bebenek, I. and Cornwell, P. D. and others},
journal = {International Journal of Toxicology},
number = {5},
pages = {379-396},
title = {Drug Development 101: A Primer},
volume = {39},
year = {2020},
doi = {10.1177/1091581820939083},
}

@unpublished{cder17,
author = {{Center for Drug Evaluation and Research (CDER)}},
month = {August},
institution = {U.S. Department of Health and Human Services, Food and Drug Administration},
title = {What is the approval process for generic drugs},
year = {2017},
url = {https://www.fda.gov/drugs/generic-drugs/what-approval-process-generic-drugs},
}

@unpublished{cder98,
author = {{Center for Drug Evaluation and Research}},
month = {December},
institution = {U.S. Department of Health and Human Services, Food and Drug Administration},
title = {Guidance for industry: Variations in a drug product that may be included in a single ANDA},
year = {1998},
url = {https://www.fda.gov/files/drugs/published/Variations-in-Drug-Products-that-May-Be-Included-in-a-Single-ANDA.pdf},
}

@techreport{cber18,
author = {{Center for Biologics Evaluation and Research, Center for Drug Evaluation and Research, and Center for Vetrinary Medicine}},
shortauthor = {{CBER, CDER, and CVM}},
month = {May},
institution = {U.S. Department of Health and Human Services, Food and Drug Administration},
title = {Structured product labeling (SPL) implementation guide with validation procedures},
year = {2018},
url = {https://www.fda.gov/media/84201/download},
}

@inproceedings{cg16,
address = {New York},
author = {Chen, T. and Guestrin, C.},
booktitle = {In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining},
pages = {785-794},
publisher = {ACM},
title = {XGBoost: A Scalable Tree Boosting System},
year = {2016},
eprint = {https://doi.org/10.1145/2939672.2939785},
}

@techreport{cbo21,
author = {{Congressional Budget Office}},
month = {April},
title = {Research and development in the pharmaceutical industry},
year = {2021},
url = {https://www.cbo.gov/publication/57025},
}

@techreport{crs21,
author = {{Congressional Research Service}},
month = {February},
title = {Drug Prices: The role of patents and regulatory exclusivities},
year = {2021},
url = {https://crsreports.congress.gov/product/pdf/R/R46679},
}

@techreport{cl19,
author = {Conrad, R. and Lutter, R.},
institution = {U.S. Department of Health and Human Services, Food and Drug Administration},
month = {December},
title = {Generic Competition and Drug Prices: New Evidence Linking Greater Generic Competition and Lower Generic Drug Prices},
year = {2019},
url = {https://www.fda.gov/media/133509/download},
note = {Accessed 11/7/2022},
}

@techreport{dc21,
author = {{Deloitte Centre for Health Solutions}},
month = {April},
title = {Nurturing growth: Measuring the return from pharmaceutical innovation},
year = {2021},
url = {https://www2.deloitte.com/content/dam/Deloitte/uk/Documents/life-sciences-health-care/Measuring-the-return-of-pharmaceutical-innovation-2021-Deloitte.pdf},
}

@article{dpfbk18,
author = {Dave, C. and Pawar, A. and Fox, E. and Brill, G. and Kesselheim, A.},
journal = {Value in Health},
number = {11},
pages = {1286-1290},
title = {Predictors of drug shortages and association with generic drug prices: A retrospective cohort study},
volume = {21},
year = {2018},
url = {https://doi.org/10.1016/j.jval.2018.04.1826},
}

@article{dlhba21,
author = {Dima, Alden and Lukens, Sarah and Hodkiewicz, Melinda and Sexton, Thurston and Brundage, Michael P.},
title = {Adapting natural language processing for technical text},
journal = {Applied AI Letters},
volume = {2},
number = {3},
pages = {e33},
keywords = {domain adaptation, maintenance records, natural language processing, technical data, technical language processing},
doi = {https://doi.org/10.1002/ail2.33},
}

@article{f19,
author = {Frerebeau, N.},
journal = {Journal of Open Source Software},
pages = {1821},
number = {44},
title = {{tabula: An R Package for Analysis, Seriation and Visualization of Archaeological Count Data}},
volume = {4},
year = {2019},
doi = {10.21105/joss.01821},
}

@book{dhmn21,
author = {Keith M. Drake and Robert He and Thomas G. McGuire and Alice K. Ndikumana},
publisher = {National Bureau of Economic Research},
title = {No Free Launch: At-Risk Entry by Generic Drug Firms},
year = {2021},
url = {https://doi.org/10.3386/w29131},
}

@article{lmu21,
author = {Lötsch, J. and Malkusch, S. and Ultsch, A.},
journal = {PLoS ONE},
number = {8},
pages = {e0255838},
title = {Optimal distribution-preserving downsampling of large biomedical data sets (opdisDownsampling)},
volume = {16},
year = {2021},
url = {https://doi.org/10.1371/journal.pone.0255838},
}

@online{dd22,
author = {{Drug Database}},
title = {FDA orange book patents},
year = {N. D.},
url = {https://drugdatabase.info/fda-orange-book-patents/},
unidentified = {Accessed 10/15/2022},
}

@article{fa12,
author = {{Food, Drug and Cosmetic Act}},
title = {21 U.S.C § 355 et seq},
year = {2012},
url = {https://www.govinfo.gov/content/pkg/USCODE-2012-title21/pdf/USCODE-2012-title21.pdf},
}

@book{htf17,
author = {Hastie, T. and Tibshirani, R. and Friedman, J.},
pages = {245, 312-313},
publisher = {Springer},
title = {The Elements of Statistical Learning. 2nd Edition},
year = {2017},
}

@article{clm20,
author = {Carrier, M. and Lemley, M. and Miller, S.},
journal = {Hastings Law Journal},
pages = {2},
title = {Playing Both Sides? Branded Sales, Generic Drugs, and Antitrust Policy},
volume = {71},
year = {2020},
url = {https://repository.uchastings.edu/hastings_law_journal/vol71/iss2/3},
}

@article{h09,
author = {Hornecker, J.},
journal = {U.S. Pharm},
number = {6},
pages = {(Generic Drug Review Supplement) 26-30},
title = {Generic drugs: History, approval process, and current challenges},
volume = {34},
year = {2009},
}

@article{kp21,
author = {Kusynová, Z., Pauletti, G., van den Ham, H., Leufkens, H., & Mantel-Teeuwisse, A.},
journal = {Journal of pharmaceutical sciences},
number = {5},
pages = {1318–1324},
title = {Unmet Medical Need as a Driver for Pharmaceutical Sciences - A Survey Among Scientists},
volume = {111},
doi = {https://doi.org/10.1016/j.xphs.2021.10.002},
}

@article{lmvc20,
author = {Ledley, F.and McCoy, S. and Vaughan, G. and Cleary, E.},
journal = {JAMA},
number = {9},
pages = {834–843},
title = {Profitability of large pharmaceutical companies compared with other large public companies.},
volume = {323},
year = {2020},
doi = {https://doi.org/10.1001/jama.2020.0442},
}

@article{lcrs16,
author = {Lee, C. and Chen, X. and Romanelli, R. and Segal, J.},
journal = {Journal of Pharmaceutical Policy and Practice},
month = {September},
number = {9},
pages = {1},
title = {Forces influencing generic drug development in the United States: a narrative review},
volume = {26},
year = {2016},
doi = {https://doi.org/10.1186/s40545-016-0079-1},
}

@article{l19,
author = {Lichtenberg, F.},
journal = {International Health},
number = {5},
pages = {403-416},
title = {How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000-2013},
volume = {11},
year = {2016},
doi = {https://doi.org/10.1093/inthealth/ihz003},
}

@unpublished{nlm22,
author = {{National Library of Medicine}},
month = {August},
note = {DailyMed},
title = {SPL resources},
year = {2022},
url = {https://dailymed.nlm.nih.gov/dailymed/spl-resources-all-drug-labels.cfm},
}

@techreport{ow13,
author = {Olson, L. and Wendling, B.},
institution = {Federal Trade Commission},
month = {April},
title = {The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period},
year = {2013},
url = {https://www.ftc.gov/reports/estimating-effect-entry-generic-drug-prices-using-hatch-waxman-exclusivity},
}

@techreport{usc13,
institution = {35 U.S.C § 154},
title = {Contents and term of patents, provisional rights},
year = {2013},
}

@unpublished{p21,
author = {Pandas},
title = {API Reference},
year = {2021},
url = {https://pandas.pydata.org/pandas-docs/stable/reference/index.html},
}

@unpublished{p22,
author = {pyPDF2},
title = {Welcome to pyPDF2},
year = {2022},
url = {https://pypdf2.readthedocs.io/en/latest/index.html},
}

@article{rgbjm22,
author = {Reddy,M.,Ganesh,G.,Babu,B.,Jagadeesan,R. & MR,P.},
journal = {Acta Marisiensis - Seria Medica},
number = {1},
pages = {28-34},
title = {Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration},
volume = {68},
doi = {https://doi.org/10.2478/amma-2022-0004},
}

@article{rw05,
author = {Reiffen, D. and Ward, M.},
journal = {The Review of Economics and Statistics},
number = {1},
pages = {37-49},
title = {Generic Drug Industry Dynamics},
volume = {87},
year = {2005},
doi = {https://doi.org/10.1162/0034653053327694},
}

@article{rlgk21,
author = {Rome, B. N. and Lee, C. C. and Gagne, J. J. and Kesselheim, A. S.},
journal = {Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
number = {6},
pages = {804-811},
title = {Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017},
volume = {24},
year = {2021},
doi = {https://doi.org/10.1016/j.jval.2020.12.020},
}

@article{rj14,
author = {Russo, A. A. and Johnson, J.},
journal = {Cold Spring Harbor perspectives in medicine},
number = {2},
pages = {a020933},
title = {Research use exemptions to patent infringement for drug discovery and development in the United States},
volume = {5},
year = {2014},
url = {https://doi.org/10.1101/cshperspect.a020933},
}

@LEGISLATION{dpr84,
  TITLE                = {Drug price competition and patent term restoration act},
  TITLEADDON           = {of 1984},
  LOCATION             = {Pub. L. No. 98-417, 98 Stat. 1585},
  URL                  = {https://www.govinfo.gov/content/pkg/STATUTE-98/pdf/STATUTE-98-Pg1585.pdf},
  DATE                 = {1984}
}

@article{sl21,
author = {Sarica, S. and Luo, J.},
journal = {PLoS ONE},
number = {8},
pages = {e0254937},
title = {Stopwords in technical language processing},
volume = {16},
year = {2021},
doi = {https://doi.org/10.1371/journal.pone.0254937},
}

@techreport{slb21,
author = {Sertkaya, A. and Lord, A. and Berger, C.},
institution = {Eastern Research Group. Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services},
month = {December},
title = {Cost of generic drug development and approval},
year = {2021},
url = {https://aspe.hhs.gov/reports/cost-generic-drugs},
}

@article{sh22,
author = {Sun, D. Gao and W. Hu and Zhou, Simon},
journal = {Acta Pharmaceutica Sinica B},
month = {July},
number = {7},
pages = {3049-3062},
title = {Why 90\% of clinical drug development fails and how to improve it},
volume = {12},
year = {2022},
doi = {https://doi.org/10.1016/j.apsb.2022.02.002},
}

@article{te09,
author = {Tamimi, N. and Ellis, P.},
journal = {Nephron Clin Pract},
pages = {c125–c131},
title = {Drug development: from concept to marketing!},
volume = {113},
year = {2009},
doi = {10.1159/000232592},
}

@book{fda05,
author = {{United States Food and Drug Administration}},
title = {Approved drug products with therapeutic equivalence evaluations. 25th to 42nd Editions},
year = {2005 to 2022},
institution = {U.S. Department of Health and Human Services},
url = {https://www.thefdalawblog.com/orange-book-archives/},
note = {Retrieved from The FDA Law Blog, 9/2/2022},
}

@unpublished{dcat22,
author = {{Dcat ValueChainInsights}},
month = {July},
note = {Value Chain Insights},
title = {Big Pharma’s Manufacturing Investments},
year = {2022},
url = {https://www.dcatvci.org/features/big-pharmas-manufacturing-investments/},
}

@article{mm09,
author = {Midha, K. and McKay, G},
journal = {The AAPS journal},
title = {Bioequivalence; its history, practice, and future},
year = {2009},
volume = {11},
number = {4},
pages = {664-670},
doi = {https://doi.org/10.1208/s12248-009-9142-z},
}

@Manual{ta15,
title = {{rpart: Recursive Partitioning and Regression Trees}},
author = {Terry Therneau and Beth Atkinson},
year = {2019},
note = {R package version 4.1-15},
url = {https://CRAN.R-project.org/package=rpart},
}

@online{asa18,
author = {{Comittee on Professional Ethics of the American Statistical Association}},
title = {Ethical Guidelines for Statistical Practice},
institution = {The American Statistical Association},
year = {2018},
month = {April},
Day = {14},
url = {https://www.amstat.org/asa/files/pdfs/EthicalGuidelines.pdf},
}

@article{liu16,
title={An overview of topic modeling and its current applications in bioinformatics},
author={Liu, Lin and Tang, Lin and Dong, Wen and Yao, Shaowen and Zhou, Wei},
journal={SpringerPlus},
volume={5},
number={1},
pages={1-22},
year={2016},
publisher={SpringerOpen},
}

@article{rst19,
title={{stm: An R Package for Structural Topic Models}},
volume={91},
url={https://www.jstatsoft.org/index.php/jss/article/view/v091i02},
doi={10.18637/jss.v091.i02},
number={2},
journal={Journal of Statistical Software},
author={Roberts, Margaret E. and Stewart, Brandon M. and Tingley, Dustin},
year={2019},
pages={1–40},
}

@article{lw10,
title={Considerations in Developing a Target Product Profile for Parenteral Pharmaceutical Products},
volume={11},
url={https://www.jstatsoft.org/index.php/jss/article/view/v091i02},
doi={10.1208/s12249-010-9521-x},
number={3},
journal={AAPS PharmSciTech},
author={Lambert, William},
year={2010},
pages={1476-1481},
}